Tokyo Tape
Sign in
← Sumitomo Chemical

Half-year report · HY

4005.TEDINET S100X029
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.10T2025-04-01 → 2025-09-30Cons.Revenue IFRS
Revenue¥2.61T2024-04-01 → 2025-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.24T2024-04-01 → 2024-09-30Cons.Revenue IFRS
Operating income¥103.7bn2025-04-01 → 2025-09-30Cons.Operating profit loss IFRS
Operating income¥121.2bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Profit before tax¥87.9bn2025-04-01 → 2025-09-30Cons.Profit loss before tax IFRS
Profit before tax¥58.1bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥30.5bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥39.7bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥38.6bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥6.5bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥90.9bn2025-04-01 → 2025-09-30Cons.Profit loss IFRS
Net income¥42.7bn2024-04-01 → 2025-03-31Cons.Profit loss IFRS (5-year summary)
Net income−¥20.3bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Total assets¥3.36Tat 2025-09-30Cons.Assets IFRS
Total assets¥3.44Tat 2025-03-31Cons.Assets IFRS
Total assets¥3.72Tat 2024-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.18Tat 2025-09-30Cons.Liabilities IFRS
Total liabilities¥2.37Tat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥1.18Tat 2025-09-30Cons.Equity IFRS
Net assets / equity¥1.07Tat 2025-03-31Cons.Equity IFRS
Net assets / equity¥1.09Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥1.16Tat 2024-03-31vCons.Equity IFRS
Equity (owners)¥958.7bnat 2025-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥900.8bnat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥909.8bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥161.2bnat 2025-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥209.8bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥273.4bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥217.4bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥57.7bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥233.0bn2024-04-01 → 2025-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥63.5bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥16.7bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥85.2bn2024-04-01 → 2025-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥74.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥114.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥300.8bn2024-04-01 → 2025-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥75.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥24.262025-04-01 → 2025-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥23.592024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-3.992024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥24.252025-04-01 → 2025-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥23.582024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
Equity ratio28.5%at 2025-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.5%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥47.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥22.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-04-01 → 2025-09-30¥24.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30¥3.2bn
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥36.6bn
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥36.6bn
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥16.2bn
Advanced Medical Solutionsreportable segmentrevenue2025-04-01 → 2025-09-30¥27.5bn
Advanced Medical Solutionsreportable segmentrevenue external2025-04-01 → 2025-09-30¥21.1bn
Advanced Medical Solutionsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥6.4bn
Advanced Medical Solutionsreportable segmentsegment profit2025-04-01 → 2025-09-30−¥1.4bn
Agro And Life Solutionsreportable segmentrevenue2025-04-01 → 2025-09-30¥213.5bn
Agro And Life Solutionsreportable segmentrevenue external2025-04-01 → 2025-09-30¥213.0bn
Agro And Life Solutionsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥504m
Agro And Life Solutionsreportable segmentsegment profit2025-04-01 → 2025-09-30¥11.2bn
Essential And Green Materialsreportable segmentrevenue2025-04-01 → 2025-09-30¥331.6bn
Essential And Green Materialsreportable segmentrevenue external2025-04-01 → 2025-09-30¥329.1bn
Essential And Green Materialsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥2.4bn
Essential And Green Materialsreportable segmentsegment profit2025-04-01 → 2025-09-30−¥18.6bn
ICT And Mobility Solutionsreportable segmentrevenue2025-04-01 → 2025-09-30¥284.9bn
ICT And Mobility Solutionsreportable segmentrevenue external2025-04-01 → 2025-09-30¥283.5bn
ICT And Mobility Solutionsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥1.5bn
ICT And Mobility Solutionsreportable segmentsegment profit2025-04-01 → 2025-09-30¥33.1bn
Sumitomo Pharmareportable segmentrevenue2025-04-01 → 2025-09-30¥227.1bn
Sumitomo Pharmareportable segmentrevenue external2025-04-01 → 2025-09-30¥226.1bn
Sumitomo Pharmareportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥1.1bn
Sumitomo Pharmareportable segmentsegment profit2025-04-01 → 2025-09-30¥97.3bn
—segment totalrevenue2025-04-01 → 2025-09-30¥1.08T
—segment totalrevenue external2025-04-01 → 2025-09-30¥1.07T
—segment totalrevenue intersegment2025-04-01 → 2025-09-30¥11.8bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥121.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥85.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥50.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥34.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥19.4bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥45.1bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥45.1bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥16.3bn
Advanced Medical Solutionsreportable segmentrevenue2024-04-01 → 2024-09-30¥31.8bn
Advanced Medical Solutionsreportable segmentrevenue external2024-04-01 → 2024-09-30¥26.8bn
Advanced Medical Solutionsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥5.0bn
Advanced Medical Solutionsreportable segmentsegment profit2024-04-01 → 2024-09-30¥355m
Agro And Life Solutionsreportable segmentrevenue2024-04-01 → 2024-09-30¥225.8bn
Agro And Life Solutionsreportable segmentrevenue external2024-04-01 → 2024-09-30¥225.0bn
Agro And Life Solutionsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥830m
Agro And Life Solutionsreportable segmentsegment profit2024-04-01 → 2024-09-30¥14.2bn
Essential And Green Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥453.8bn
Essential And Green Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥450.9bn
Essential And Green Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥2.8bn
Essential And Green Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30−¥34.8bn
ICT And Mobility Solutionsreportable segmentrevenue2024-04-01 → 2024-09-30¥309.5bn
ICT And Mobility Solutionsreportable segmentrevenue external2024-04-01 → 2024-09-30¥307.5bn
ICT And Mobility Solutionsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥2.0bn
ICT And Mobility Solutionsreportable segmentsegment profit2024-04-01 → 2024-09-30¥43.6bn
Sumitomo Pharmareportable segmentrevenue2024-04-01 → 2024-09-30¥180.4bn
Sumitomo Pharmareportable segmentrevenue external2024-04-01 → 2024-09-30¥180.4bn
Sumitomo Pharmareportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥47m
Sumitomo Pharmareportable segmentsegment profit2024-04-01 → 2024-09-30¥3.0bn
—segment totalrevenue2024-04-01 → 2024-09-30¥1.20T
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.19T
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥10.7bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥26.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 916
ItemContextValueUnit
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1InterimDuration-105000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSInterimDuration-114000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1InterimDuration-38124000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSInterimDuration12564000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1InterimDuration7974000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSInterimDuration-3856000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1InterimDuration-30329000000JPY
Total of items that may be reclassified to profit or loss oci IFRSInterimDuration8652000000JPY
Other comprehensive income IFRSPrior1InterimDuration-50147000000JPY
Other comprehensive income IFRSInterimDuration28517000000JPY
Comprehensive income IFRSPrior1InterimDuration-70432000000JPY
Comprehensive income IFRSInterimDuration119446000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1InterimDuration-51297000000JPY
Comprehensive income attributable to owners of parent IFRSInterimDuration67530000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1InterimDuration-19135000000JPY
Comprehensive income attributable to non controlling interests IFRSInterimDuration51916000000JPY
Comprehensive income IFRSPrior1InterimDuration-70432000000JPY
Comprehensive income IFRSInterimDuration119446000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember89938000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember237000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember578175000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-8355000000JPY
Equity IFRSPrior2YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember83448000000JPY
Equity IFRSPrior2YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_RetainedEarningsIFRSMember-6527000000JPY
Profit loss IFRSPrior1InterimDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-15298000000JPY
Other comprehensive income IFRSPrior1InterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember181000000JPY
Comprehensive income IFRSPrior1InterimDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1InterimDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1InterimDuration_RetainedEarningsIFRSMember-6527000000JPY
Comprehensive income IFRSPrior1InterimDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1InterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-15298000000JPY
Comprehensive income IFRSPrior1InterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember181000000JPY
Issuance of new shares ss IFRSPrior1InterimDuration_ShareCapitalIFRSMember120000000JPY
Issuance of new shares ss IFRSPrior1InterimDuration_CapitalSurplusIFRSMember120000000JPY
Issuance of new shares ss IFRSPrior1InterimDuration_RetainedEarningsIFRSMember－JPY
Issuance of new shares ss IFRSPrior1InterimDuration_TreasurySharesIFRSMember－JPY
Issuance of new shares ss IFRSPrior1InterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Issuance of new shares ss IFRSPrior1InterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1InterimDuration_ShareCapitalIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1InterimDuration_CapitalSurplusIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass